vaccine

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reading now: 838
www.clickorlando.com

LONDON – AstraZeneca's release Monday of encouraging data about its coronavirus vaccine from its U.S. trial raised hopes that the drug company could bury doubts about the shot and put a troubled rollout behind it.

But hours later, U.S. officials issued an unusual statement expressing concerns the company had included “outdated information” from its study and that it may have provided “an incomplete view of the efficacy data.” A company spokesman said Tuesday it was “looking into it.” Even before this latest stumble, AstraZeneca had made missteps in reporting data and faced a blood clot scare.

Health officials worried that those past issues could cause lasting harm to the shot that is key to global efforts to stop the pandemic and undermine

Read more on clickorlando.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA